BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr | ₹3.02 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹24 Cr |
Mar2023 | ₹23 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹3.02 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹24 Cr | 6.39 | |
Mar2023 | ₹23 Cr | 107.27 | |
Mar2022 | ₹11 Cr | -14.92 | |
Mar2021 | ₹13 Cr | 330.75 | |
Mar2020 | ₹3.02 Cr | - |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹199.1 Cr | -1.7% | 12% | 2.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -1.7% |
12% |
2.5% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses